Diabetes is a global epidemic that affects an estimated 828 million people worldwide.1 In the past decade, diabetes has emerged as a major challenge to health systems globally, and about 42% of people ...

Increasing antibiotic treatment adherence among children lowered average treatment durations by up to 1.7 days.

Antimicrobial-resistant (AMR) “superbugs” contribute to more than 4.5 million deaths globally per year and threaten to make ...

Hospital-onset antimicrobial-resistant infections increased across U.S. hospitals during and beyond the COVID-19 pandemic.

Conclusions For annual mass azithromycin distribution programme to an entire community, there may be no additional benefit of increasing antibiotic coverage above the WHO’s 80% target. Trial ...

So what does this mean for skin health and diseases?” Though there are many studies out there that introduce potential solutions to the problem of antibiotic resistance, “what was fun and interesting ...

Published in PNAS Nexus, Heloisa Ehalt Macedo and colleagues calculate that worldwide humans consume around 29,200 tonnes of the 40 most used antibiotics.After metabolism and wastewater treatment ...

Researchers discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhoea. These substances trigger a self-destruction program ...

This antibiotic activates a self-destruction mechanism in the bacteria by disrupting a toxin-antitoxin system unique to gonococci, sparing other microorganisms and human cells.

The survey comprised two parts: the ward form, which captured ward details (name, specialty, bed count, and antibiotic use), and the patient form, which documented demographics, antimicrobial therapy, ...

In short: The Food and Drug Administration focuses on bugs instead of patients. You probably think “antibiotic resistance” means that a bacterial infection can’t be cured by any antibiotics.

A 7-day course of antibiotics for patients hospitalized with bloodstream infections was just as effective as a 14-day course, according to results of the randomized, open-label BALANCE trial.